Figure 2

Survival analysis for target lesion failure and patient-oriented composite outcome up to 3 years of follow-up. A) Target lesion failure. B) Patient-oriented composite outcome. C) Target vessel myocardial infarction D) Cardiac death E) Target lesion revascularization. Target lesion failure defined as a composite of cardiac death, myocardial infarction (not clearly attributed to a nontarget vessel), or clinically indicated target lesion revascularization by percutaneous or surgical methods. Patient-oriented composite outcome included all-cause mortality, any myocardial infarction (includes nontarget vessel territory), and any revascularization (includes all target and nontarget vessel, regardless of percutaneous or surgical methods). Log rank p value or Breslow p value were presented. Abbreviations: EES, everolimus-eluting stent; R-ZES, Resolute zotarolimus eluting-stent.